Literature DB >> 33353076

A Survey of Alzheimer's Disease Early Diagnosis Methods for Cognitive Assessment.

Juan Manuel Fernández Montenegro1, Barbara Villarini2, Anastassia Angelopoulou2, Epaminondas Kapetanios2, Jose Garcia-Rodriguez3, Vasileios Argyriou1.   

Abstract

Dementia is a syndrome that is characterised by the decline of different cognitive abilities. A high rate of deaths and high cost for detection, treatments, and patients care count amongst its consequences. Although there is no cure for dementia, a timely diagnosis helps in obtaining necessary support, appropriate medication, and maintenance, as far as possible, of engagement in intellectual, social, and physical activities. The early detection of Alzheimer Disease (AD) is considered to be of high importance for improving the quality of life of patients and their families. In particular, Virtual Reality (VR) is an expanding tool that can be used in order to assess cognitive abilities while navigating through a Virtual Environment (VE). The paper summarises common AD screening and diagnosis techniques focusing on the latest approaches that are based on Virtual Environments, behaviour analysis, and emotions recognition, aiming to provide more reliable and non-invasive diagnostics at home or in a clinical environment. Furthermore, different AD diagnosis evaluation methods and metrics are presented and discussed together with an overview of the different datasets.

Entities:  

Keywords:  Alzheimer Screening; Virtual Environments; behaviour analysis; cognitive tests; dementia

Mesh:

Year:  2020        PMID: 33353076      PMCID: PMC7766748          DOI: 10.3390/s20247292

Source DB:  PubMed          Journal:  Sensors (Basel)        ISSN: 1424-8220            Impact factor:   3.576


  45 in total

1.  E-health in low- and middle-income countries: findings from the Center for Health Market Innovations.

Authors:  Trevor Lewis; Christina Synowiec; Gina Lagomarsino; Julian Schweitzer
Journal:  Bull World Health Organ       Date:  2012-05-01       Impact factor: 9.408

2.  Alterations of visual search strategy in Alzheimer's disease and aging.

Authors:  A Rösler; M E Mapstone; A K Hays; M M Mesulam; A Rademaker; D R Gitelman; S Weintraub
Journal:  Neuropsychology       Date:  2000-07       Impact factor: 3.295

3.  Facial expression in Alzheimer's disease: impact of cognitive deficits and neuropsychiatric symptoms.

Authors:  Ulrich Seidl; Ulrike Lueken; Philipp A Thomann; Andreas Kruse; Johannes Schröder
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-03       Impact factor: 2.035

4.  Initial validation of a virtual environment for assessment of memory functioning: virtual reality cognitive performance assessment test.

Authors:  Thomas D Parsons; Albert A Rizzo
Journal:  Cyberpsychol Behav       Date:  2008-02

5.  Detecting navigational deficits in cognitive aging and Alzheimer disease using virtual reality.

Authors:  Laura A Cushman; Karen Stein; Charles J Duffy
Journal:  Neurology       Date:  2008-09-16       Impact factor: 9.910

6.  Ecological validity of virtual reality daily living activities screening for early dementia: longitudinal study.

Authors:  Ioannis Tarnanas; Winfried Schlee; Magda Tsolaki; René Müri; Urs Mosimann; Tobias Nef
Journal:  JMIR Serious Games       Date:  2013-08-06       Impact factor: 4.143

7.  Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) battery.

Authors:  Natália Bezerra Mota Quental; Sonia Maria Dozzi Brucki; Orlando Francisco Amodeo Bueno
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

8.  A Novel Virtual Reality-Based Training Protocol for the Enhancement of the "Mental Frame Syncing" in Individuals with Alzheimer's Disease: A Development-of-Concept Trial.

Authors:  Silvia Serino; Elisa Pedroli; Cosimo Tuena; Gianluca De Leo; Marco Stramba-Badiale; Karine Goulene; Noemi G Mariotti; Giuseppe Riva
Journal:  Front Aging Neurosci       Date:  2017-07-27       Impact factor: 5.750

9.  A New Approach to Diagnose Parkinson's Disease Using a Structural Cooccurrence Matrix for a Similarity Analysis.

Authors:  João W M de Souza; Shara S A Alves; Elizângela de S Rebouças; Jefferson S Almeida; Pedro P Rebouças Filho
Journal:  Comput Intell Neurosci       Date:  2018-04-24

10.  Detecting Cognitive Impairment and Dementia in Deaf People: The British Sign Language Cognitive Screening Test.

Authors:  Joanna Atkinson; Tanya Denmark; Jane Marshall; Cath Mummery; Bencie Woll
Journal:  Arch Clin Neuropsychol       Date:  2015-08-04       Impact factor: 2.813

View more
  5 in total

1.  Dementia and Major Neurocognitive Disorders: Some Lessons Learned One Century after the first Alois Alzheimer's Clinical Notes.

Authors:  Donatella Rita Petretto; Gian Pietro Carrogu; Luca Gaviano; Lorenzo Pili; Roberto Pili
Journal:  Geriatrics (Basel)       Date:  2021-01-11

2.  Development and Validation of a Deep Learning Model for Earlier Detection of Cognitive Decline From Clinical Notes in Electronic Health Records.

Authors:  Liqin Wang; John Laurentiev; Jie Yang; Ying-Chih Lo; Rebecca E Amariglio; Deborah Blacker; Reisa A Sperling; Gad A Marshall; Li Zhou
Journal:  JAMA Netw Open       Date:  2021-11-01

3.  Diagnostic accuracy study of automated stratification of Alzheimer's disease and mild cognitive impairment via deep learning based on MRI.

Authors:  Xiaowen Chen; Mingyue Tang; Aimin Liu; Xiaoqin Wei
Journal:  Ann Transl Med       Date:  2022-07

4.  DailyCog: A Real-World Functional Cognitive Mobile Application for Evaluating Mild Cognitive Impairment (MCI) in Parkinson's Disease.

Authors:  Sara Rosenblum; Ariella Richardson; Sonya Meyer; Tal Nevo; Maayan Sinai; Sharon Hassin-Baer
Journal:  Sensors (Basel)       Date:  2021-03-04       Impact factor: 3.576

Review 5.  Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease.

Authors:  Anna Litwiniuk; Wojciech Bik; Małgorzata Kalisz; Agnieszka Baranowska-Bik
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.